Sunday, December 4, 2022

Tag: Phase 3 study


Lupin announces results of phase 3 study of Single-Dose Solosec for...

Lupin Pharmaceuticals announced positive top-line results from its pivotal Phase 3 clinical trial to assess efficacy and safety of single-dose Solosec (secnidazole) 2g oral...

This function has been disabled for HealthTekPak.

error: Content is protected !!